Home Prostate / Prostate Cancer BRIEF-Astrazeneca Receives Lynparza Approval In The US For Prostate Cancer

BRIEF-Astrazeneca Receives Lynparza Approval In The US For Prostate Cancer

39
0

May 20 (Reuters) – AstraZeneca PLC:

* LYNPARZA APPROVED IN THE US FOR PROSTATE CANCER

* APPROVED IN US FOR PATIENTS WITH HOMOLOGOUS RECOMBINATION REPAIR GENE-MUTATED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

* APPROVAL BY FOOD AND DRUG ADMINISTRATION WAS BASED ON RESULTS FROM PHASE III PROFOUND TRIAL Source text for Eikon: Further company coverage:

https://www.reuters.com/article/brief-astrazeneca-receives-lynparza-appr/brief-astrazeneca-receives-lynparza-approval-in-the-us-for-prostate-cancer-idUSASN00070L

Advertisements

This site uses Akismet to reduce spam. Learn how your comment data is processed.